Cry1A.105 is an engineered chimeric protein composed of domains I and II from Cry1Ab or Cry1Ac, domain III from Cry1F, and a C-terminal domain from Cry1Ac, and has insecticidal activity against a variety of pests. The Cry1A.105 protein is activated by the intestinal juice of the target pest to obtain an activated toxin fragment, which binds to the midgut epithelial cells of the pest to form holes, leading to intestinal paralysis and eventually death due to sepsis.

https://www.lifeasible.com/p/8656/recombinant-bacillus-thuringiensis-cry1a105-protein/

As a biotechnology company, Lifeasible is specialized in agricultural science, offering a wide variety of agro-related services and products for environmental and energy solutions.